European Medicines Agency Accepts Novaliq's Marketing Authorization Application for CyclASol (ciclosporin ophthalmic solution) 0.1% for the Treatment of Dry Eye Disease : vimarsana.com

European Medicines Agency Accepts Novaliq's Marketing Authorization Application for CyclASol (ciclosporin ophthalmic solution) 0.1% for the Treatment of Dry Eye Disease

European Medicines Agency Accepts Novaliq's Marketing Authorization Application for CyclASol (ciclosporin ophthalmic solution) 0.1% for the Treatment of Dry Eye Disease

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Germany , Heidelberg , Baden Wüberg , United States , America , Novaliq Gmb , Christian Roesky , Simone Angstmann Mehr , Drug Administration , Committee For Medicinal Products Human Use , European Union , Gmbh Co , Novaliq Inc , Health Sciences , Harrow Health Inc , European Medicines Agency , Novaliq Gmbh , Medicinal Products , Human Use , Chief Executive Officer , Authorization Application , Northern America , Hopp Biotech , Media Contact , Aktien Sie ,